Diagenode Revenue and Competitors
Estimated Revenue & Valuation
- Diagenode's estimated annual revenue is currently $24.2M per year.
- Diagenode's estimated revenue per employee is $155,000
Employee Data
- Diagenode has 156 Employees.
- Diagenode grew their employee count by 2% last year.
Diagenode's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Administration & HR | Reveal Email/Phone |
3 | Head Global Marketing Operations | Reveal Email/Phone |
4 | RA/QA Officer | Reveal Email/Phone |
5 | QC Officer | Reveal Email/Phone |
6 | Head Bioinformatics | Reveal Email/Phone |
7 | Regulatory Affairs Officer | Reveal Email/Phone |
8 | Creative and Digital Marketing Officer | Reveal Email/Phone |
9 | R&D Manager | Reveal Email/Phone |
10 | Product Manager - Epigenomic Services | Reveal Email/Phone |
Diagenode Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $128M | 826 | 6% | N/A | N/A |
#2 | $22.3M | 144 | -1% | N/A | N/A |
What Is Diagenode?
Diagenode is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays based in Liege, Belgium and NJ, USA. The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services. ► EPIGENETICS RESEARCH : Epigenetics is playing a revolutionary role in life sciences research. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available. ► MOLECULAR DIAGNOSTICS : Diagenode offers amplification and quantification methods for DNA targets of human infectious disease to meet the fast-paced growth of human disease diagnostics. We also provide guidance to diagnostics companies to develop epigenetics-based diagnostics. Our products are designed to make diagnostic assays simpler, faster, and of highest quality. Our kits are CE-marked and certified ISO 9001 and ISO 13485. Innovating Epigenetics Solutions, Human Infectious diseases Molecular Diagnostics, Custom Epigenetic Research Services, Real-Time qPCR detection
keywords:N/AN/A
Total Funding
156
Number of Employees
$24.2M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diagenode News
Illumina, Thermo Fisher, Diagenode, QIAGEN, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, PerkinElmer, Bio-Rad.
Illumina, Diagenode, Merck & Co, Qiagen, Thermo Fisher Scientific, Abcam, Roche Diagnostics, New England Biolabs, Sigma-Aldrich,...
Thermo Fisher; Diagenode; BGI; Active Motif; CD Genomics; Illumina; GENEWIZ; Exiqon; LC Sciences; Novogene; Qiagen; Arraystar; CeGaT GmbH; Phalanx...
This powerful solution combines our best-in-class RNA library preparation with MGI’s high-quality, cost-effective, DNA nanoballs sequencing solution, creating a unified platform to support high quality small RNA sequencing. DENVILLE, N.J. and LIEGE, Belgium (PRWEB) January 07, 2021 Diagenode, ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $50M | 284 | 6% | N/A |
#2 | N/A | 343 | -3% | N/A |
#3 | $72.4M | 467 | 9% | N/A |